Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

An exploratory study on the spatial relationship between regional cortical volume changes and white matter integrity in Multiple Sclerosis.
Incidence of multiple sclerosis among European Economic Area populations, 1985-2009: the framework for monitoring.
The economic impact of multiple sclerosis in Australia in 2010.
A pragmatic parallel arm multi-centre randomised controlled trial to assess the effectiveness and cost-effectiveness of a group-based fatigue management programme (FACETS) for people with multiple sclerosis.
Clinical, radiographic characteristics and immunomodulating changes in neuromyelitis optica with extensive brain lesions.
Goal oriented inpatient multiple sclerosis group.
Short Myelitis Lesions in Aquaporin-4-IgG-Positive Neuromyelitis Optica Spectrum Disorders.
Kaposi sarcoma in a patient with relapsing-remitting multiple sclerosis receiving fingolimod.
Neurological Dysfunction in Early Maturity of a Model for Niemann-Pick C1 Carrier Status.
Estimating a minimal clinically important difference for the EuroQol 5-dimension health status index in persons with multiple sclerosis.
Inadequacy of Clinical Trial Designs and Data to Control for the Confounding Impact of Race/Ethnicity in Response to Treatment in Multiple Sclerosis.
CCL27: Novel Cytokine with Potential Role in Pathogenesis of Multiple Sclerosis.
The Potential Roles of Aquaporin 4 in Alzheimer's Disease.
Multiple sclerosis: Daclizumab HYP shows superiority to IFN-β1a for reducing relapses in multiple sclerosis.
[Guillain-Barré syndrome in infancy: The importance of electroneuromyography].
VDJtools: Unifying Post-analysis of T Cell Receptor Repertoires.
A modified approach to inducing bone marrow stromal cells to differentiate into cells with mature Schwann cell phenotypes.
New EMA Advice for PML Prevention With Fingolimod in MS
Alterations in Functional and Structural Connectivity in Pediatric-Onset Multiple Sclerosis.
A delicate balance: role of MMP-9 in brain development and pathophysiology of neurodevelopmental disorders.
IL-11 in multiple sclerosis.
Extensive brain demyelinating lesions under natalizumab: The role of anti-natalizumab antibodies.
The role of pro- and anti-inflammatory cytokines in the pathogenesis of spontaneous canine CNS diseases.
Functional neuroimaging may quantify spinal cord demyelinating disease.
Mood disorder as the presenting manifestation of demyelination.

Pages